Computational modeling integrating transcriptomic and vulnerability responses can predict suppressors of cell death as candidate targets for cancer therapy
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 18 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Computational pipeline predicting cell death suppressors as targets for cancer therapyiScience · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255459_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1075062 and SRA study SRP489119. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 18 sample titles: 18 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8072816 BT549_DMSO_a
- GSM8072817 BT549_DMSO_b
- GSM8072818 BT549_Erastin_a
- GSM8072819 BT549_Erastin_b
- GSM8072820 BT549_RSL3_a
- GSM8072821 BT549_RSL3_b
- GSM8072822 HS578_DMSO_a
- GSM8072823 HS578_DMSO_b
- GSM8072824 HS578_Erastin_a
- GSM8072825 HS578_Erastin_b
- GSM8072826 HS578_RSL3_a
- GSM8072827 HS578_RSL3_b
- GSM8072828 SUM159_DMSO_a
- GSM8072829 SUM159_DMSO_b
- GSM8072830 SUM159_Erastin_a
- GSM8072831 SUM159_Erastin_b
- GSM8072832 SUM159_RSL3_a
- GSM8072833 SUM159_RSL3_b
- GSE338964 Computational modeling and preclinical evaluation support targeting somatic instability for Huntington’s disease treatment. 104 samples shares computational, modeling
- GSE309010 Cannabinoid-driven epigenetic remodeling of a chromatin-lipid homeostatic axis via ARID1A uncovers a metabolic vulnerability in cancer 25 samples shares vulnerability, modeling
- GSE241672 Integrating Gene Expression and Splicing Dynamics Across Dose-Response Oxidative Modulators 400 samples shares integrating
- GSE295392 PIKfyve-regulated lipid metabolism as a therapeutic vulnerability in neuroendocrine prostate cancer 82 samples shares vulnerability
- GSE336720 DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors [RNA-seq] 68 samples shares vulnerability
- GSE302078 The novel RNA polymerase I transcription inhibitor PMR-116 exploits a critical therapeutic vulnerability in a broad-spectrum of high MYC malignancies 56 samples shares vulnerability
- GSE275637 ATF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma 50 samples shares vulnerability
- GSE273787 Pathways underlying selective neuronal vulnerability in Alzheimer's disease: contrasting the vulnerable locus coeruleus to the resilient substantia nigra 44 samples shares vulnerability
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.